Emmanuelle Boulanger

Summary

Country: France

Publications

  1. ncbi Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS
    Emmanuelle Boulanger
    Department of Clinical Immunology, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, 1 avenue Claude Vellefaux, 75 475 Paris Cedex 10, France
    J Clin Oncol 23:4372-80. 2005
  2. ncbi Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma
    Emmanuelle Boulanger
    Department of Clinical Immunopathology, Hopital Saint Louis, AP HP, Paris, France
    Am J Hematol 73:143-8. 2003
  3. ncbi Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial
    Laurence Gerard
    Department of Clinical Immunology, Laboratory of Virology, Paris VII University, Paris, France
    J Clin Oncol 25:3350-6. 2007
  4. ncbi Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival
    Laurence Gerard
    Service d Immuno Hématologie Hôpital Saint Louis, AP HP, Paris, France
    J Acquir Immune Defic Syndr 30:478-84. 2002
  5. ncbi Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses
    Olivier Adotevi
    Institut National de la Sante et de la Recherche Medicale U255, Universite Rene Descartes, Unité d Immunologie Biologique, Hopital Europeen Georges Pompidou, Assistance Public Hôpitaux de Paris, France
    Clin Cancer Res 12:3158-67. 2006
  6. ncbi Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma
    Emmanuelle Boulanger
    Department of Clinical Immunology, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, Paris, France
    Haematologica 94:1170-4. 2009
  7. ncbi Polyclonal IgG4 hypergammaglobulinemia associated with plasmacytic lymphadenopathy, anemia and nephropathy
    Emmanuelle Boulanger
    Department of Clinical Immunology, Hopital Saint Louis, AP HP, Paris, France
    Ann Hematol 85:833-40. 2006
  8. ncbi High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease
    Eric Oksenhendler
    Department of Immunology and Hematology, Laboratory of Hematology, Hopital Saint Louis, 1 Ave Claude Vellefaux, 75010 Paris, France
    Blood 99:2331-6. 2002
  9. ncbi Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cells
    Emmanuelle Boulanger
    Unité d Epidémiologie et de Physiopathologie des Virus Oncogènes, Institut Pasteur, Paris, France
    Int J Cancer 115:511-8. 2005
  10. ncbi Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma
    Emmanuelle Boulanger
    Br J Haematol 141:559-61. 2008

Detail Information

Publications18

  1. ncbi Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS
    Emmanuelle Boulanger
    Department of Clinical Immunology, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, 1 avenue Claude Vellefaux, 75 475 Paris Cedex 10, France
    J Clin Oncol 23:4372-80. 2005
    ..The prognosis is poor, with reported median survival time shorter than 6 months. To date, no prognostic factor has been identified in this subset of lymphoma...
  2. ncbi Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma
    Emmanuelle Boulanger
    Department of Clinical Immunopathology, Hopital Saint Louis, AP HP, Paris, France
    Am J Hematol 73:143-8. 2003
    ..Complete remission was obtained in 3 out of 7 patients treated for AIDS-associated PEL with combined chemotherapy containing high-dose methotrexate...
  3. ncbi Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman's disease: ANRS 117 CastlemaB Trial
    Laurence Gerard
    Department of Clinical Immunology, Laboratory of Virology, Paris VII University, Paris, France
    J Clin Oncol 25:3350-6. 2007
    ..Single-agent chemotherapy is usually effective in HIV-associated multicentric Castleman's disease (MCD). However, in most patients, chemotherapy cannot be discontinued...
  4. ncbi Systemic non-Hodgkin lymphoma in HIV-infected patients with effective suppression of HIV replication: persistent occurrence but improved survival
    Laurence Gerard
    Service d Immuno Hématologie Hôpital Saint Louis, AP HP, Paris, France
    J Acquir Immune Defic Syndr 30:478-84. 2002
    ..Improvement in the overall survival rate in the post-HAART period was associated with more intensive chemotherapy regimens, increased complete remission rate, and a likely benefit of continuation or introduction of HAART...
  5. ncbi Immunogenic HLA-B*0702-restricted epitopes derived from human telomerase reverse transcriptase that elicit antitumor cytotoxic T-cell responses
    Olivier Adotevi
    Institut National de la Sante et de la Recherche Medicale U255, Universite Rene Descartes, Unité d Immunologie Biologique, Hopital Europeen Georges Pompidou, Assistance Public Hôpitaux de Paris, France
    Clin Cancer Res 12:3158-67. 2006
    ..To increase the applicability of hTERT-based immunotherapy, we set out to identify CTL epitopes in hTERT restricted by HLA-B*0702 molecule, a common MHC class I allele...
  6. ncbi Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma
    Emmanuelle Boulanger
    Department of Clinical Immunology, Hopital Saint Louis, Assistance Publique Hopitaux de Paris, Paris, France
    Haematologica 94:1170-4. 2009
    ....
  7. ncbi Polyclonal IgG4 hypergammaglobulinemia associated with plasmacytic lymphadenopathy, anemia and nephropathy
    Emmanuelle Boulanger
    Department of Clinical Immunology, Hopital Saint Louis, AP HP, Paris, France
    Ann Hematol 85:833-40. 2006
    ..The increased IgG4 production was found to be mediated by soluble factor(s), most probably secreted by activated T cells, which did not require the signal transducer and activator of transcription 6 signaling pathway...
  8. ncbi High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease
    Eric Oksenhendler
    Department of Immunology and Hematology, Laboratory of Hematology, Hopital Saint Louis, 1 Ave Claude Vellefaux, 75010 Paris, France
    Blood 99:2331-6. 2002
    ..In contrast, the PEL and PEL-like NHL may implicate a different original infected cell whose growth is promoted by the cytokine-rich environment of the MCD lesions...
  9. ncbi Mono/oligoclonal pattern of Kaposi Sarcoma-associated herpesvirus (KSHV/HHV-8) episomes in primary effusion lymphoma cells
    Emmanuelle Boulanger
    Unité d Epidémiologie et de Physiopathologie des Virus Oncogènes, Institut Pasteur, Paris, France
    Int J Cancer 115:511-8. 2005
    ..Several of these mechanisms, not mutually exclusive, might coexist in a single tumor...
  10. ncbi Bortezomib (PS-341) in patients with human herpesvirus 8-associated primary effusion lymphoma
    Emmanuelle Boulanger
    Br J Haematol 141:559-61. 2008
  11. ncbi Human herpesvirus 8 (HHV-8)-associated peritoneal primary effusion lymphoma (PEL) in two HIV-negative elderly patients
    Emmanuelle Boulanger
    Unit of Epidemiology and Physiopathology of Oncogenic Viruses, Institut Pasteur, Paris, France
    Am J Hematol 76:88-91. 2004
    ..Compared to AIDS-related PEL, these two cases displayed distinct features in particular the advanced age of patients, as observed for Mediterranean KS, and the absence of EBV coinfection...
  12. ncbi HHV8-related non-Hodgkin's lymphoma of the spermatic cord in a patient with HIV-associated multicentric Castleman disease
    Emmanuelle Boulanger
    Am J Hematol 72:70-1. 2003
  13. ncbi Mucosa-associated lymphoid tissue lymphoma in patients with human immunodeficiency virus infection
    Emmanuelle Boulanger
    Br J Haematol 140:470-4. 2008
  14. ncbi Extracavitary tumor after primary effusion lymphoma: relapse or second distinct lymphoma?
    Emmanuelle Boulanger
    Haematologica 92:1275-6. 2007
    ..HHV-8 episome clonality might help identify which event takes place...
  15. ncbi Analysis of TCR, pT alpha, and RAG-1 in T-acute lymphoblastic leukemias improves understanding of early human T-lymphoid lineage commitment
    Vahid Asnafi
    Department of Biological and Clinical Hematology, , France
    Blood 101:2693-703. 2003
    ..TCR gene configuration identified progressive T-lymphoid restriction. T-ALLs, therefore, provide homogeneous expansions of minor human lymphoid precursor populations that can aid in the understanding of healthy human T-cell development...
  16. ncbi Nonhuman primates might be highly susceptible to cross-species infectivity by human alpha-herpesviruses
    Brice Lefaux
    Vet Pathol 41:302-4. 2004
  17. ncbi Novel gamma-2-herpesvirus of the Rhadinovirus 2 lineage in gibbons
    Renan Duprez
    Institut Pasteur, Paris, France
    Emerg Infect Dis 10:899-902. 2004
    ..The finding of this new gibbon virus, which clusters with a related chimpanzee virus in the rhadinovirus 2 genogroup, suggests the existence of a novel gamma-2-herpesvirus in humans...